EA201001243A1 - Кристаллические формы n-[2-(диэтиламино)этил]-5-[(5-фтор-1,2-дигидро-2-оксо-3н-индол-3-илиден)метил]-2,4-диметил-1н-пиррол-3-карбоксамида и способы их получения - Google Patents
Кристаллические формы n-[2-(диэтиламино)этил]-5-[(5-фтор-1,2-дигидро-2-оксо-3н-индол-3-илиден)метил]-2,4-диметил-1н-пиррол-3-карбоксамида и способы их полученияInfo
- Publication number
- EA201001243A1 EA201001243A1 EA201001243A EA201001243A EA201001243A1 EA 201001243 A1 EA201001243 A1 EA 201001243A1 EA 201001243 A EA201001243 A EA 201001243A EA 201001243 A EA201001243 A EA 201001243A EA 201001243 A1 EA201001243 A1 EA 201001243A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pirrol
- carboxamide
- ways
- obtaining
- crystal forms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
В заявке описаны новые кристаллические формы сунитиниба и способы их получения.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08004143A EP2098521A1 (en) | 2008-03-06 | 2008-03-06 | Crystal forms of N-[2-(diethylamino) ethyl]-5-[fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrolle-3-carboxamide and methods for their prepparation |
PCT/EP2009/001568 WO2009109388A1 (en) | 2008-03-06 | 2009-03-05 | Crystal forms of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide and methods for their preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201001243A1 true EA201001243A1 (ru) | 2011-04-29 |
EA020067B1 EA020067B1 (ru) | 2014-08-29 |
Family
ID=39590734
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201001243A EA020067B1 (ru) | 2008-03-06 | 2009-03-05 | Полиморфная форма iii n-[2-(диэтиламино)этил]-5-[(5-фтор-1,2-дигидро-2-оксо-3н-индол-3-илиден)метил]-2,4-диметил-1н-пиррол-3-карбоксамида и способ её получения |
Country Status (15)
Country | Link |
---|---|
US (1) | US20110034703A1 (ru) |
EP (3) | EP2098521A1 (ru) |
JP (1) | JP2011513349A (ru) |
KR (1) | KR101604501B1 (ru) |
CN (1) | CN101965342B (ru) |
AU (1) | AU2009221458A1 (ru) |
CA (1) | CA2714441A1 (ru) |
EA (1) | EA020067B1 (ru) |
ES (1) | ES2478821T3 (ru) |
IL (1) | IL207984A (ru) |
PL (1) | PL2247585T3 (ru) |
PT (1) | PT2247585E (ru) |
SI (1) | SI2247585T1 (ru) |
WO (1) | WO2009109388A1 (ru) |
ZA (1) | ZA201005796B (ru) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2253629A1 (en) * | 2007-11-21 | 2010-11-24 | Teva Pharmaceutical Industries Ltd. | Polymorphs of racemic sunitinib malate, compositions containing them and preparation thereof |
KR20100135910A (ko) | 2008-04-16 | 2010-12-27 | 낫코 파마 리미티드 | 수니티닙 염기의 신규한 다형 형태 |
EP2313371B1 (en) | 2008-06-13 | 2012-08-15 | Medichem, S.A. | Process for preparing a 3-pyrrole substituted 2-indolinone malate salt |
WO2010023473A2 (en) * | 2008-08-25 | 2010-03-04 | Generics [Uk] Limited | Novel crystalline form and processes for its preparation |
JP2012500838A (ja) * | 2008-08-25 | 2012-01-12 | ジェネリクス・(ユーケー)・リミテッド | スニチニブの新規な多形およびその調製方法 |
EP2528913A1 (en) | 2010-01-29 | 2012-12-05 | Ranbaxy Laboratories Limited | Crystalline forms of l-malic acid salt of sunitinib |
WO2011100325A2 (en) | 2010-02-09 | 2011-08-18 | Sicor Inc. | Polymorphs of sunitinib salts |
EP2858628A1 (en) * | 2012-06-25 | 2015-04-15 | Bayer HealthCare LLC | Topical ophthalmological pharmaceutical composition containing sunitinib |
CN103833733B (zh) * | 2012-11-21 | 2017-08-25 | 广东东阳光药业有限公司 | 一种替尼类药物新晶型 |
WO2015031604A1 (en) | 2013-08-28 | 2015-03-05 | Crown Bioscience, Inc. | Gene expression signatures predictive of subject response to a multi-kinase inhibitor and methods of using the same |
RU2567535C1 (ru) * | 2014-10-01 | 2015-11-10 | Олег Ростиславович Михайлов | КРИСТАЛЛИЧЕСКАЯ ε-МОДИФИКАЦИЯ N-[2-(ДИЭТИЛАМИНО)ЭТИЛ]-5-[(Z)-(5-ФТОР-1,2-ДИГИДРО-2-ОКСО-3Н-ИНДОЛ-3-ИЛИДЕН)МЕТИЛ]-2,4-ДИМЕТИЛ-1Н-ПИРРОЛ-3-КАРБОКСАМИД МАЛАТА, СПОСОБ ЕЕ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕЕ ОСНОВЕ |
CN106884206A (zh) * | 2017-03-17 | 2017-06-23 | 青岛大学 | 一种有机非线性光学晶体用籽晶的生长方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020010203A1 (en) | 1999-12-22 | 2002-01-24 | Ken Lipson | Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
NZ520640A (en) * | 2000-02-15 | 2005-04-29 | Upjohn Co | Pyrrole substituted 2-indolinone protein kinase inhibitors |
PT3168218T (pt) * | 2001-08-15 | 2019-01-11 | Pharmacia & Upjohn Co Llc | Um cristal compreendendo um sal de ácido l-málico de n-[2- (dietilamino)etil]-5-[(5-fluoro-1,2-dihidro-2-oxo-3h-indol- 3-ilideno)metil]-2,4-dimetil-1h-pirrol-3-carboxamida para utilização como um medicamento |
TWI259081B (en) | 2001-10-26 | 2006-08-01 | Sugen Inc | Treatment of acute myeloid leukemia with indolinone compounds |
US7119209B2 (en) * | 2002-02-15 | 2006-10-10 | Pharmacia & Upjohn Company | Process for preparing indolinone derivatives |
-
2008
- 2008-03-06 EP EP08004143A patent/EP2098521A1/en not_active Withdrawn
-
2009
- 2009-03-05 WO PCT/EP2009/001568 patent/WO2009109388A1/en active Application Filing
- 2009-03-05 CA CA2714441A patent/CA2714441A1/en not_active Abandoned
- 2009-03-05 EA EA201001243A patent/EA020067B1/ru not_active IP Right Cessation
- 2009-03-05 US US12/918,612 patent/US20110034703A1/en not_active Abandoned
- 2009-03-05 CN CN200980107316.8A patent/CN101965342B/zh not_active Expired - Fee Related
- 2009-03-05 ES ES09717772.9T patent/ES2478821T3/es active Active
- 2009-03-05 EP EP13158832.9A patent/EP2604603A1/en not_active Withdrawn
- 2009-03-05 EP EP09717772.9A patent/EP2247585B1/en active Active
- 2009-03-05 KR KR1020107019864A patent/KR101604501B1/ko active IP Right Grant
- 2009-03-05 JP JP2010549060A patent/JP2011513349A/ja active Pending
- 2009-03-05 SI SI200930926T patent/SI2247585T1/sl unknown
- 2009-03-05 PL PL09717772T patent/PL2247585T3/pl unknown
- 2009-03-05 PT PT97177729T patent/PT2247585E/pt unknown
- 2009-03-05 AU AU2009221458A patent/AU2009221458A1/en not_active Abandoned
-
2010
- 2010-08-13 ZA ZA2010/05796A patent/ZA201005796B/en unknown
- 2010-09-05 IL IL207984A patent/IL207984A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
AU2009221458A1 (en) | 2009-09-11 |
WO2009109388A8 (en) | 2010-10-07 |
US20110034703A1 (en) | 2011-02-10 |
EP2098521A1 (en) | 2009-09-09 |
ES2478821T3 (es) | 2014-07-23 |
KR101604501B1 (ko) | 2016-03-17 |
PL2247585T3 (pl) | 2014-09-30 |
IL207984A0 (en) | 2010-12-30 |
EP2604603A1 (en) | 2013-06-19 |
CA2714441A1 (en) | 2009-09-11 |
EA020067B1 (ru) | 2014-08-29 |
CN101965342A (zh) | 2011-02-02 |
ZA201005796B (en) | 2011-04-28 |
PT2247585E (pt) | 2014-07-17 |
IL207984A (en) | 2016-07-31 |
WO2009109388A1 (en) | 2009-09-11 |
EP2247585A1 (en) | 2010-11-10 |
CN101965342B (zh) | 2014-07-30 |
JP2011513349A (ja) | 2011-04-28 |
EP2247585B1 (en) | 2014-04-30 |
SI2247585T1 (sl) | 2014-08-29 |
KR20100125300A (ko) | 2010-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201001243A1 (ru) | Кристаллические формы n-[2-(диэтиламино)этил]-5-[(5-фтор-1,2-дигидро-2-оксо-3н-индол-3-илиден)метил]-2,4-диметил-1н-пиррол-3-карбоксамида и способы их получения | |
EA201270149A1 (ru) | Ингибиторы bace | |
EA201001680A1 (ru) | Соединения бензолсульфонамидтиазола и оксазола | |
EA201070856A1 (ru) | Кристаллические формы диметоксидоцетаксела и способы их получения | |
EA201490922A1 (ru) | ПРОИЗВОДНЫЕ ГИДАНТОИНА, ПОЛЕЗНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Kv3-КАНАЛОВ | |
EA201071264A1 (ru) | Аминодигидротиазиновые производные в качестве ингибиторов bace для лечения болезни альцгеймера | |
CY2016017I1 (el) | Συνθεση για θεραπεια πνευμονικης υπερτασης | |
EA200971077A1 (ru) | Гетероциклические модуляторы киназы | |
EA201170151A1 (ru) | Пиперидиниловые агонисты gpcr | |
EA201200049A1 (ru) | 1,3-дизамещенные производные имидазолидин-2-она в качестве ингибиторов cyp 17 | |
DK2315756T3 (da) | 1,2,5-oxadiazoler som inhibitorer af indolamin-2,3-dioxygenase | |
EA201171151A1 (ru) | Кристаллические трипептидные ингибиторы эпоксикетон-протеазы | |
DK2489361T3 (da) | Anvendelse af cellepermeable peptidinhibitorer af JNK-signaltransduktionsvejentil behandling af forskellige sygdomme. | |
EA201170227A1 (ru) | Имидазолкарбоксамиды | |
EA201070127A1 (ru) | Способы лечения легочной гипертензии, родственных заболеваний и нарушений и композиции для их осуществления | |
EA200901653A1 (ru) | ОПОСРЕДУЕМОЕ PHKi ИНГИБИРОВАНИЕ ЭКСПРЕССИИ АЛЬФА-EnaC | |
CL2011000846A1 (es) | Compuestos heterociclicos sustituidos; composicion farmaceutica; y su uso para el tratamiento de la hepatitis c. | |
DK2182950T3 (da) | Anvendelse af 4-(pyrrolidin-1-yl)quinolinforbindelser til at dræbe klinisk latente mikroorganismer | |
CL2011000087A1 (es) | Compuestos derivados de heteroarilo sustituido, inhibidores de los receptores dgat1; composicion farmaceutica; y su uso para tratar la diabetes tipo ll y obesidad. | |
EA201171063A1 (ru) | Фармацевтические составы олмесартана | |
DK2041093T3 (da) | Til behandling af GPR38-receptor medierede sygdomme anvendelige piperazinylderivativer | |
ATE466854T1 (de) | 1h-indol-6-ylpiperazin-1-ylmethanonderivate zur verwendung als h3-rezeptormodulatoren | |
EA201000069A1 (ru) | Новые гербициды | |
DK2285416T3 (da) | Konjugat til behandlingen af mesotheliom | |
EA201170481A1 (ru) | Сокристаллы |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ KZ KG MD TJ TM |